Mammogram Mail- and Phone-based Interventions
Randomized Comparison of Mail- and Phone-based Interventions Promoting Mammogram Screening
1 other identifier
interventional
14,386
1 country
1
Brief Summary
The project aims to evaluate four different versions and modalities of interventions encouraging mammogram screening among all eligible women due or overdue for screening. The evaluation will compare among the following forms of outreach to help determine whether (a) live calls are more effective at increasing mammogram screening than other forms of outreach and (b) each form of outreach is more effective than no outreach: (1) a postcard, (2) a letter, (3) an auto-dialer phone message, and (4) a live call from a care gaps team. The interventions will be rolled out over many months, allowing for comparisons of effectiveness against those who have not yet been contacted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started May 2023
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2023
CompletedStudy Start
First participant enrolled
May 10, 2023
CompletedFirst Posted
Study publicly available on registry
May 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedOctober 10, 2024
October 1, 2024
1.2 years
April 28, 2023
October 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mammogram completed
Record of completed mammogram (yes/no), for comparing postcards, letters, and auto-dialer messages with live calls
In the 180 days following the patient's intervention send date
Mammogram completed
Record of completed mammogram (yes/no), for comparing postcards, letters, auto-dialer messages, and live calls with controls
In the 120 days following the patient's intervention send date
Other Outcomes (3)
Mammogram completed
In the 180 days following the patient's intervention send date
Breast malignancy risk detected
In the 210 days following the patient's intervention send date
Mammogram appointment scheduled
In the 30 days following the patient's intervention send date
Study Arms (4)
Standard postcard
ACTIVE COMPARATORPatients in this arm will receive a postcard with words and an image, typical of outreach in prior years, encouraging them to schedule their annual mammograms.
Formal letter
EXPERIMENTALPatients in this arm will receive a letter from the Geisinger Health Plan (on Geisinger letterhead) noting that they're overdue for a mammogram and encouraging them to schedule.
Auto-dialer
EXPERIMENTALPatients in this arm will receive a call from an auto-dialer with a message noting that they're overdue for a mammogram and encouraging them to schedule.
Live call
EXPERIMENTALPatients in this arm will receive a call from a Geisinger Health Plan representative noting that they're overdue for a mammogram and encouraging them to schedule (and helping them schedule if they are interested).
Interventions
Postcard with phone number to call for help scheduling a mammogram.
Auto-dialer with option to press button for help scheduling a mammogram.
Eligibility Criteria
You may qualify if:
- Female Geisinger Health Plan members between ages 52 and 74 as of December 31, 2023
- Overdue for annual mammogram
- Continuously enrolled with the Geisinger Health Plan as of October 1, 2021
- Can be contacted via both phone and mail
You may not qualify if:
- Geisinger Health Plan members on a do-not-contact list
- Had a mammogram as of October 1, 2021
- In hospice, using hospice services, or receiving palliative care as of January 1, 2023
- Medicare members 66 years of age or above at time of outreach, who are institutionalized or have both frailty and advanced illness
- Had a bilateral mastectomy at any time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Geisinger Cliniclead
Study Sites (1)
Geisinger
Danville, Pennsylvania, 17822, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amir Goren, PhD
Geisinger Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Program Director, Behavioral Insights Team
Study Record Dates
First Submitted
April 28, 2023
First Posted
May 11, 2023
Study Start
May 10, 2023
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
October 10, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- By the paper's online publication date. Data will remain available for as long as the Open Science Framework hosts it.
- Access Criteria
- The data on the Open Science Framework will be open to anyone requesting that information.
Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.